Controversial trade pacts threatening access to vital asthma medicines: expert – Shanghai Daily (subscription)

Controversial trade pacts threatening access to vital asthma medicines: expert
Shanghai Daily (subscription)
WELLINGTON, May 6 (Xinhua) — New international trade pacts, such as the under-negotiation Trans-Pacific Partnership (TPP), are putting access to quality medicines at risk for millions of asthma sufferers around the world, chair of the Global Asthma

and more »

View full post on asthma – Google News

Stopping Controversial Asthma Drugs Could Have Downside: Study – U.S. News & World Report

Stopping Controversial Asthma Drugs Could Have Downside: Study
U.S. News & World Report
The U.S. Food and Drug Administration has warned that asthma patients who take both long-acting beta-agonist and inhaled corticosteroid medications should be cautious about using them together once their condition is under control. Long-acting
Asthma Worsens with Step-Off TherapyMedPage Today
Study Questions Recommendation to Discontinue LABA Therapy in Asthma Science Daily (press release)

all 7 news articles »

View full post on asthma – Google News

Stopping Controversial Asthma Drugs Could Have Downside: Study – Newsday (subscription)


Newsday (subscription)

Stopping Controversial Asthma Drugs Could Have Downside: Study
Newsday (subscription)
It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests. The U.S. Food and Drug Administration has warned that

View full post on asthma – Google News